Long-term suppression of pituitary-gonadal function with three-month depot of leuprorelin acetate in a girl with central precocious puberty

Hormone Research

Volumn 58, Issue 6, 2002, Pages 292-296

  Schroeter, Manuela ^a   Baus, Inka ^a   Sippell, Wolfgang G ^a   Partsch, Carl Joachim ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bone maturation; GnRH agonist; GnRH test; Gonadotropins; Growth; Leuprorelin; Precocious puberty

Indexed keywords

GONADORELIN AGONIST; LEUPRORELIN; ESTRADIOL; FOLLITROPIN; HORMONE ANTAGONIST; LUTEINIZING HORMONE;

ARTICLE; BONE MATURATION; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS GONAD SYSTEM; OVARY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; UTERUS; BLOOD; BODY HEIGHT; CHILD; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECT; ECHOGRAPHY; FEMALE GENITAL SYSTEM; GROWTH, DEVELOPMENT AND AGING; HYPOPHYSIS;

BODY HEIGHT; CHILD; DELAYED-ACTION PREPARATIONS; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GENITALIA, FEMALE; HORMONE ANTAGONISTS; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; OVARY; PITUITARY GLAND; PUBERTY, PRECOCIOUS;

EID: 0036438585     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066445     Document Type: Article

References (23)

1. Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB: Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: A potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981;52:370-372.
2. Partsch C-J, Hummelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL: Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: Influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group. Horm Res 1993;39:111-117.
3. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S: Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatment. Acta Paediatr 1994;83:1052-1056.
4. Carel J-C, Lahlou N, Guazarotti L, Joubert-Collin M, Roger M, Colle M, the French Leu-prorelin Trial Group, Chaussain JL: Treatment of central precocious puberty with depot leuprorelin. Eur J Endocrinol 1995;132:699-704.
5. Partsch C-J, Peter M, Brand M, Sippell WG: Treatment of progressive central precocious puberty with leuprorelin depot. Monatsschr Kinderheilkd 1999;147:638-647.
6. Oostdijk W, Hummelink R, Odink RJH, Partsch CJ, Drop SLS, Lorenzen F, Sippell WG: Treatment of children with central precocious puberty by a slow-release GnRH agonist. Eur J Pediatr 1990:149:308-313.
7. Paterson WF, McNeilL E, Reid S, Hollman AS, Donaldson MD: Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty. Arch Dis Child 1998;79:323-327.
8. Reinken L, van Oost G: Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Klin Pädiatr 1992;204:129-133.
9. Cole TJ, Freeman JV, Preece MA: Body mass index reference curves for the UK, 1990. Arch Dis Child 1995;73:25-29.
10. Buzi F, Pilotta A, Dordoni D, Lombardi A, Zaglio S, Adlard P: Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatr 1998;87:1138-1145.
11. Salardi S, Orsini LF, Cacciari E, Bovicelli L, Tassoni P, Reggiani A: Pelvic ultrasonography in premenarcheal girls: Relation to puberty and sex hormone concentrations. Arch Dis Child 1985;60:120-125.
12. Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, Ed 1. Stanford, University Press, 1950.
13. Bayley N, Pinneau S: Tables for predicting adult height from skeletal age. J Pediatr 1952;40:423-441.
14. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z: Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997;47:54-61.
15. Partsch C-J, Hummelink R, Sippell WG: Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradiometric assay. J Clin Chem Clin Biochem 1990;28:49-52.
16. Partsch C-J, Hummelink R, Lorenzen F, Sippell WG: The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: The stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche. Monatsschr Kinderheilk 1989;137:284-288.
17. Okada H: One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev 1997;28:43-70.
18. Fornara P, Jocham D: Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma. Urol Int 1996;56(suppl 1):18-22.
19. Oostdijk W, Partsch C-J, Drop SLS, Sippell WG: Hormonal evaluation during and after long-term treatment with a slow-release GnRH agonist of children with central precocious puberty: Effect on final height; in Plant TM, Lee PA (eds): The Neurobiology of Puberty. Bristol, Journal of Endocrinology, 1995, pp 319-325.
20. Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, Wilson DM: Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr 1992;121:634-640.
21. Tonini G, Marinoni S, Forleo V, Rustico M: Local reactions to luteinizing hormone releasing hormone analog therapy. J Pediatr 1995;126:159-160.
22. Tanaka T, Hibi I, Kato K, Saito S, Shimizu N, Suwa S, Nakajima H: A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group. Endocrinol Jpn 1991;38:369-376.
23. Parker KL, Baens-Bailon RG, Lee PA: Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 1991;73:50-52.